DAVID A. RELMAN (Chair), Stanford University, Palo Alto, California

MARGARET A. HAMBURG (Vice Chair), Nuclear Threat Initiative/Global Health & Security Initiative, Washington, DC

DAVID W. K. ACHESON, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Rockville, Maryland

RUTH L. BERKELMAN, Emory University, Center for Public Health Preparedness and Research, Rollins School of Public Health, Atlanta, Georgia

ENRIQUETA C. BOND, Burroughs Wellcome Fund, Research Triangle Park, North Carolina

ROGER G. BREEZE, Centaur Science Group, Washington, DC

STEVEN J. BRICKNER, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut

GAIL H. CASSELL, Eli Lilly & Company, Indianapolis, Indiana

BILL COLSTON, Lawrence Livermore National Laboratory, Livermore, California

RALPH L. ERICKSON, Global Emerging Infections Surveillance and Response System, Department of Defense, Silver Spring, Maryland

MARK B. FEINBERG, Merck Vaccine Division, Merck & Co., West Point, Pennsylvania

J. PATRICK FITCH, National Biodefense Analysis and Countermeasures Center, Frederick, Maryland

DARRELL R. GALLOWAY, Medical S&T Division, Defense Threat Reduction Agency, Fort Belvoir, Virginia

S. ELIZABETH GEORGE, Biological and Chemical Countermeasures Program, Department of Homeland Security, Washington, DC

JESSE L. GOODMAN, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland

EDUARDO GOTUZZO, Instituto de Medicina Tropical–Alexander von Humbolt, Universidad Peruana Cayetano Heredia, Lima, Peru

JO HANDELSMAN, College of Agricultural and Life Sciences, University of Wisconsin, Madison

CAROLE A. HEILMAN, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

DAVID L. HEYMANN, Polio Eradication, World Health Organization, Geneva, Switzerland

PHIL HOSBACH, New Products and Immunization Policy, Sanofi Pasteur, Swiftwater, Pennsylvania

JAMES M. HUGHES, Global Infectious Diseases Program, Emory University, Atlanta, Georgia

STEPHEN A. JOHNSTON, Arizona BioDesign Institute, Arizona State University, Tempe

GERALD T. KEUSCH, Boston University School of Medicine and Boston University School of Public Health, Massachusetts

RIMA F. KHABBAZ, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

LONNIE J. KING, Center for Zoonotic, Vectorborne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

GEORGE W. KORCH, U.S. Army Medical Research Institute for Infectious Diseases, Fort Detrick, Maryland

STANLEY M. LEMON, School of Medicine, University of Texas Medical Branch, Galveston

EDWARD M c SWEEGAN, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

STEPHEN S. MORSE, Center for Public Health Preparedness, Columbia University, New York

MICHAEL T. OSTERHOLM, Center for Infectious Disease Research and Policy, School of Public Health, University of Minnesota, Minneapolis

GEORGE POSTE, Arizona BioDesign Institute, Arizona State University, Tempe

JOHN C. POTTAGE, JR., GlaxoSmithKline, Collegeville, Pennsylvania

GARY A. ROSELLE, Central Office, Veterans Health Administration, Department of Veterans Affairs, Washington, DC

JANET SHOEMAKER, Office of Public Affairs, American Society for Microbiology, Washington, DC

P. FREDERICK SPARLING, University of North Carolina, Chapel Hill

BRIAN J. STASKAWICZ, Department of Plant and Microbial Biology, University of California, Berkeley

TERENCE TAYLOR, International Council for the Life Sciences, Washington, DC

MURRAY TROSTLE, U.S. Agency for International Development, Washington, DC